ZYNE
Zynerba Pharmaceuticals, Inc.
No insider bought or sold Zynerba Pharmaceuticals, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
ZYNE over the last year
Prices for ZYNE aren't in yet.
ZYNE after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
10 insider filings since 2016, newest first
ZYNEBuy
John P. Butler · Director
$32KAug 22
ZYNEBuy
Armando Anido · COB, Chief Exec. Officer
$89K+4.0%Aug 7
ZYNEBuy
James E Fickenscher · CFO
$51K+70.0%Aug 7
ZYNEBuy
Michael Rapp · 10% owner
$157K+1.0%May 2
ZYNEBuy
Michael Rapp · 10% owner
$93K+1.0%Mar 23
ZYNEBuy
Michael Rapp · 10% owner
$195K+1.0%Jan 3
ZYNEBuy
Michael Rapp · 10% owner
$974K+7.0%Oct 23
ZYNEBuy
Armando Anido · COB, Chief Exec. Officer
$99K+1.0%May 16
ZYNEBuy
James E Fickenscher · CFO
$103K+74.0%May 16
ZYNESell
Suzanne M. Hanlon · Sec, GC, VP HR
$32K−7.0%Aug 17
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.